Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Clinical trial NCT00412581 · COMPLETED
Trial details
- NCT number
- NCT00412581
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.